Medical Information
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.
Not a healthcare professional? Go to the patient or caregiver website.

SODIUM CHLORIDE INJECTION Principal Display Panel (Sodium Chloride 0.45% and 0.9% ADD-Vantage Diluent)

PRINCIPAL DISPLAY PANEL - 50 mL Bag Label - NDC 0409-7101

PULL INNER PLUG/STOPPER
AND MIX DRUG BEFORE USE

ADD-Vantage™ Unit
NDC 0409-7101-68

0.9% SODIUM
CHLORIDE
Injection, USP

50
mL

EACH 100 mL CONTAINS SODIUM CHLORIDE
900 mg. ELECTROLYTES (mEq/LITER): SODIUM
154 mEq; CHLORIDE 154 mEq. 308 mOsmol/LITER (calc.).
pH 5.6 (4.5 TO 7.0) FOR USE ONLY WITH ADD-Vantage™
SYSTEM COMPONENTS. SINGLE-DOSE CONTAINER.
FOR I.V. USE. USUAL DOSAGE: SEE PACKAGE INSERT.
STERILE, NONPYROGENIC. USE ONLY IF SOLUTION IS
CLEAR AND CONTAINER IS UNDAMAGED. MUST NOT BE
USED IN SERIES CONNECTIONS. Rx ONLY

3
v

CONTAINS DEHP

IM-3516

Hospira

HOSPIRA, INC., LAKE FOREST, IL 60045 USA

PRINCIPAL DISPLAY PANEL - 50 mL Bag Label - NDC 0409-7101

PRINCIPAL DISPLAY PANEL - 50 mL Bag Overwrap Label - NDC 0409-7101

TO OPEN – PEEL AT NOTCH

Five/ADD-Vantage™ Units

For use only with ADD-Vantage™ system components.

The overwrap is a moisture barrier. Do not remove units from overwrap until ready for use. Use units
promptly when pouch is opened. After removing the overwrap, check for minute leaks by squeezing
container firmly. If leaks are found, discard unit as sterility may be impaired. Store at 20 to 25°C
(68 to 77°F). [See USP Controlled Room Temperature.]

Rx only

WR-0424

HOSPIRA, INC., LAKE FOREST, IL 60045 USA
Hospira

PRINCIPAL DISPLAY PANEL - 50 mL Bag Overwrap Label - NDC 0409-7101

PRINCIPAL DISPLAY PANEL - 250 mL Bag Label - NDC 0409-7101

LOT
EXP.

PULL INNER PLUG/STOPPER
AND MIX DRUG BEFORE USE

ADD-Vantage™ Unit
NDC 0409-7101-04

0.9%
SODIUM CHLORIDE

Injection, USP

250
mL

EACH 100 mL CONTAINS
SODIUM CHLORIDE 900 mg.
ELECTROLYTES (mEq/LITER):
SODIUM 154 mEq; CHLORIDE
154 mEq. 308 mOsmol/LITER
(calc.). pH 5.6 (4.5 TO 7.0).
FOR USE ONLY WITH
ADD-Vantage™ SYSTEM
COMPONENTS. SINGLE-
DOSE CONTAINER. FOR
INTRAVENOUS USE. USUAL
DOSAGE: SEE INSERT.
STERILE, NONPYROGENIC.
USE ONLY IF SOLUTION IS
CLEAR AND CONTAINER IS
UNDAMAGED. MUST NOT
BE USED IN SERIES
CONNECTIONS.
Rx ONLY

3
v

CONTAINS DEHP

IM-3518
Hospira

HOSPIRA, INC., LAKE FOREST, IL 60045 USA

PRINCIPAL DISPLAY PANEL - 250 mL Bag Label - NDC 0409-7101

PRINCIPAL DISPLAY PANEL - 250 mL Bag Overwrap Label - NDC 0409-7101

One/ADD-Vantage™ Unit
TO OPEN–PEEL AT CORNER

For use only with ADD-Vantage™ system components.

The overwrap is a moisture barrier. Do not remove unit from overwrap
until ready for use. Use unit promptly when pouch is opened. Store at
20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] Protect
from freezing. See insert. After removing the overwrap, check for minute
leaks by squeezing container firmly. If leaks are found, discard unit as
sterility may be impaired.

Rx only

WR-0425

HOSPIRA, INC., LAKE FOREST, IL 60045 USA
Hospira

PRINCIPAL DISPLAY PANEL - 250 mL Bag Overwrap Label - NDC 0409-7101

PRINCIPAL DISPLAY PANEL - 50 mL Bag Label - NDC 0409-7132

PULL INNER PLUG/STOPPER
AND MIX DRUG BEFORE USE

ADD-Vantage™ Unit
NDC 0409-7132-68

0.45% SODIUM
CHLORIDE
Injection, USP

50
mL

EACH 100 mL CONTAINS SODIUM CHLORIDE
450 mg. ELECTROLYTES (mEq/LITER): SODIUM
77 mEq; CHLORIDE 77 mEq. 154 mOsmol/LITER
(calc.). pH 5.6 (4.5 TO 7.0) FOR USE ONLY WITH
ADD-Vantage™ SYSTEM COMPONENTS. SINGLE-
DOSE CONTAINER. FOR I.V. USE. USUAL DOSAGE: SEE
PACKAGE INSERT. STERILE, NONPYROGENIC. USE
ONLY IF SOLUTION IS CLEAR AND
CONTAINER IS UNDAMAGED.
MUST NOT BE USED IN SERIES CONNECTIONS.

3
v

CONTAINS DEHP

Rx ONLY

IM-3519

HOSPIRA, INC., LAKE FOREST, IL 60045 USA

PRINCIPAL DISPLAY PANEL - 50 mL Bag Label - NDC 0409-7132

PRINCIPAL DISPLAY PANEL - 50 mL Bag Overwrap Label - NDC 0409-7132

TO OPEN – PEEL AT NOTCH

Five/ADD-Vantage™ Units

For use only with ADD-Vantage™ system components.

The overwrap is a moisture barrier. Do not remove units from overwrap until ready for use. Use units
promptly when pouch is opened. After removing the overwrap, check for minute leaks by squeezing
container firmly. If leaks are found, discard unit as sterility may be impaired. Store at 20 to 25°C
(68 to 77°F). [See USP Controlled Room Temperature.]

Rx only

WR-0424

HOSPIRA, INC., LAKE FOREST, IL 60045 USA
Hospira

PRINCIPAL DISPLAY PANEL - 50 mL Bag Overwrap Label - NDC 0409-7132

PRINCIPAL DISPLAY PANEL - 250 mL Bag Label - NDC 0409-7132

LOT
EXP.

PULL INNER PLUG/STOPPER
AND MIX DRUG BEFORE USE

ADD-Vantage™ Unit
NDC 0409-7132-04

0.45%
SODIUM CHLORIDE

Injection, USP

250
mL

EACH 100 mL CONTAINS
SODIUM CHLORIDE 450 mg.
ELECTROLYTES (mEq/LITER):
SODIUM 77 mEq; CHLORIDE
77 mEq. 154 mOsmol/LITER
(calc). pH 5.6 (4.5 TO 7.0). FOR
USE ONLY WITH ADD-Vantage™
SYSTEM COMPONENTS.
SINGLE-DOSE CONTAINER. FOR
INTRAVENOUS USE. USUAL
DOSAGE: SEE INSERT. STERILE,
NONPYROGENIC. USE ONLY
IF SOLUTION IS CLEAR AND
CONTAINER IS UNDAMAGED.
MUST NOT BE USED IN SERIES
CONNECTIONS.

Rx ONLY

3
v

CONTAINS DEHP

IM-3521
HOSPIRA, INC., LAKE FOREST, IL 60045 USA
Hospira

PRINCIPAL DISPLAY PANEL - 250 mL Bag Label - NDC 0409-7132

PRINCIPAL DISPLAY PANEL - 250 mL Bag Overwrap Label - NDC 0409-7132

One/ADD-Vantage™ Unit
TO OPEN–PEEL AT CORNER

For use only with ADD-Vantage™ system components.

The overwrap is a moisture barrier. Do not remove unit from overwrap
until ready for use. Use unit promptly when pouch is opened. Store at
20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] Protect
from freezing. See insert. After removing the overwrap, check for minute
leaks by squeezing container firmly. If leaks are found, discard unit as
sterility may be impaired.

Rx only

WR-0425

HOSPIRA, INC., LAKE FOREST, IL 60045 USA
Hospira

PRINCIPAL DISPLAY PANEL - 250 mL Bag Overwrap Label - NDC 0409-7132
Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.

*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.

*9AM-5PM ET Monday to Friday; excluding holidays.

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product: (800) 438-1985

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns at 1-800-FDA-1088 or www.fda.gov/MedWatch